SmartAnalyst highlights Key KRAS presentations at AACR2022, on effectively drugging the KRASG12C mutants, and what to expect in the next wave of KRAS pathway inhibitors – other therapeutic nodes on the pathway, combination, and tumor genotypes.

Click here to learn more: AACR 2022 – Orchestrating the KRAS Pathway to Benefit Patients